SAMHSA’s Center for Substance Abuse Prevention

Drug Testing Advisory Board

Matthew J. Aumen Acting Designated Federal Official

July 26, 2016

Call to Order 3

General Comments 4

• Posted on website ­http://www.samhsa.gov/about-us/advisory­councils/drug-testing-advisory-board-dtab• FRNs• Agendas• Open session meeting proceedings• Minutes• Open session presentations

• Questions• Public comments

Save the Dates 5

• Dates for FY 17 DTAB meetings will be announced at a later date

Housekeeping 6

• On-site guests • Restrooms • Food/drink options

• Web conference participants • Verizon • Adobe Connect

• All participants • Silencing of electronic devices and minimizing

background noises

Welcome 7

Welcome to Our DTAB Members 8

• Jennifer A. Collins, Ph.D., DABFT • Anthony G. Costantino, Ph.D., D-ABFT • James L. Ferguson, D.O., FASAM • Ronald R. Flegel, B.S., MT(ASCP), M.S. • Gregory F. Grinstead, Ph.D., DABCC • Paul Harris • Costantino (Tony) Ioannone

Welcome to Our DTAB Members

9

• Courtney Lias, Ph.D. • Patrice Kelly, J.D. • Susan P. Mills, M.S., MT(ASCP), NRCC,

FTS-ABFT • Madeline A. Montgomery, B.S., FTS-ABFT

• Christine M. Moore, Ph.D., D.Sc., DABCC

• Buddha D. Paul, Ph.D. • Jasbir Singh, Ph.D., DABCC

DWP Staff 10

• Ronald Flegel • Sean Belouin • Anastasia Donovan

• Deborah Galvin • Eugene Hayes

• Giselle Hersh • Charles LoDico • Brian Makela • Coleen Sanderson

• Hyden Shen

Federal Partners 11

• COL Tom Martin (DoD) • LTC Kenneth Biskner (DOJ) • Patrice Kelly (DOT) • Courtney Lias (FDA) • Ian Rucker (OGC) • Connie Foster (OGC) • Michael Cala (ONDCP)

Disclaimer 12

• Today’s presentations do not reflect the views of HHS or SAMHSA, nor does it constitute an endorsement of the presenter, the presenter’s views, the presentation’s subject matter, the organizations mentioned during the presentation, or other entities, methods, products and information referenced during the presentation.

Opening Remarks 13

• Ron R. Flegel, B.S., MT(ASCP), M.S. • Director, DWP